Immunotherapy cuts heart disease risk in arthritis patients

Rheumatoid arthritis is an autoimmune disease in which cytokines such as tumour necrosis factor-alpha (TNFI) and interfero-gamma (IFN), which normally protect the body,replicas de relojes attack healthy cells

The findings showed that the combination of two anticytokines containing extra-low doses of antibodies against TNFI and IFN could improve the efficacy of standard rheumatoid arthritis therapy and decrease heart disease risk www.cheapshoesite.com.

They are also at increased cardiovascular risk, particularly if their rheumatoid arthritis is not controlled,” said Aida Babaeva, Professor at Volgograd State Medical University in Russia.